Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact.

Clin Transl Sci · 2025 · PMC12033005 · PMID 40286322

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Although a slight trend was observed between C avg,dose1 and probability of response (Figure 4c,d ), logistic regression modeling showed that C avg,dose1 was not a predictor for ORR ( p > 0.05).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.